SDPS-29 SERUM-DERIVED CD47 AS A MARKER OF TUMOR BURDENAND OUTCOME IN GBM PATIENTS – CORRELATIVE ANALYSISOF TUMOR LOCATION, RADIATION THERAPY VOLUMES,AND SURVIVAL

Glioblastomas (GBM) are the most aggressive central nervous system tumors exhibiting near universal recurrence following resection and chemoradiation (CRT). CD47 is an integrin-associated transmembrane protein associated with immunomodulation, invasion, and stemness that is highly expressed in GBM....

Descripción completa

Detalles Bibliográficos
Autores principales: Jagasia, Sarisha, Krauze, Andra, Zhao, Yingdong, Li, Ming-Chung, Tasci, Erdal, Zgela, Theresa Cooley, Sproull, Mary, Mackey, Megan, Tofilon, Philip, Camphausen, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Final Category: Screening/Diagnostics/Prognostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402367/
http://dx.doi.org/10.1093/noajnl/vdad070.084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402367/
http://dx.doi.org/10.1093/noajnl/vdad070.084

Ejemplares similares